title: IMP reamination to AMP in rat skeletal muscle fiber types.
abstract: Inosine 5'-monophosphate (IMP) reamination in skeletal muscle fiber sections of the rat hindlimb was studied. High IMP concentrations were established during ischemic contractions in each fiber section: 3.1, 2.8, or 0.6 mumol/g in the fast-twitch white (FTW), fast-twitch red (FTR), and slow-twitch red (STR) muscle sections, respectively. Thereafter blood flow was restored and stimulation was discontinued to allow reamination of IMP. After 0, 2, 5, 10, 15, or 20 min of recovery, muscle sections were freeze-clamped and analyzed for metabolite contents. IMP was nearly fully reaminated after 10 and 20 min of recovery in STR and FTR muscles, respectively. Reamination in TW fibers was delayed and slower, with only 50% of the IMP reaminated after 20 min of recovery. Significant recovery (approximately 75%) of phosphocreatine occurs in each fiber section before the onset of reamination. Reamination was also evaluated after high-speed treadmill running with or without inhibition of reamination by hadacidin. Running resulted in large accumulations of IMP in FTW and FTR fibers (3.5 and 1.4 mumul/g, respectively); IMP in FTR fibers was higher with hadacidin treatment. Reamination after running was much greater in FTR than in FTW fibers and was associated with recovery of phosphocreatine. After running, the purine degradation products inosine and hypoxanthine were increased in FTW and FTR fibers in normal and hadacidin-treated animals. Plasma inosine, hypoxanthine, and urate increased after exercise; concentrations continued to increase if reamination was inhibited by hadacidin. These results demonstrate that when muscle IMP is increased, subsequent degradation and loss of purines occur. Rapid reamination should minimize the quantity of purine lost from muscle and limit the metabolic cost of replenishing purines by the de novo synthesis or salvage pathways.
authors.affiliation: Department of Physiology, State University of New York, Syracuse 13210, USA.
authors.forename: P C
authors.initials: PC
authors.lastname: Tullson
authors.forename: P G
authors.initials: PG
authors.lastname: Arabadjis
authors.forename: K W
authors.initials: KW
authors.lastname: Rundell
authors.forename: R L
authors.initials: RL
authors.lastname: Terjung
mesh_terms: D000249:Adenosine Monophosphate / Q000096:biosynthesis*; D000588:Amines / Q000378:metabolism*; D000818:Animals; D001769:Blood / Q000378:metabolism; D004558:Electric Stimulation; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D007291:Inosine Monophosphate / Q000378:metabolism*; D008297:Male; D009043:Motor Activity / Q000502:physiology; D018482:Muscle, Skeletal / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000588:Amines; D007291:Inosine Monophosphate; D000249:Adenosine Monophosphate; C001321:hadacidin; D005998:Glycine